Floatz logo

Moviprep

Colon Carcinoma

Unidade Local de Saúde do Alto Ave, EPEUNKNOWNPhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
65/ 100

Competitive context

154 Active assets in the Colon Carcinoma cohort.

Asset / SponsorPhaseRating
Floxuridine
City of Hope Medical Center
Phase 2BBB
Fluorouracilum
Akeso
Phase 4BB
Pertuzumab
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3BB
Oxaliplatin
Sun Yat-sen University
Phase 3BB
Trastuzumab
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3BB

View all 50 →

Same molecule, other indications

Moviprep is also rated in:

colorectal cancerActive
BB
Indicative · Phase 4
67 / 100
View asset →
melanomaActive
CCC
Indicative · Phase 2
51 / 100
View asset →
large intestine disorderDormant
D
Indicative · N/A
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →